Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Systane Complete** is an Alcon over-the-counter ophthalmic lubricant artificial-tear nanoemulsion developed for temporary relief of dry-eye symptoms across aqueous-deficient, evaporative, and mixed dry eye. Its active demulcent is propylene glycol, supported by hydroxypropyl guar and nano-sized lipid droplets, including dimyristoyl phosphatidylglycerol, which physically lubricate the ocular surface, improve tear-film coverage, and reduce tear evaporation. University of Alabama at Birmingham studies evaluated off-label application around or directly onto soft daily disposable contact lenses and found improved contact-lens comfort and dryness symptoms without reported treatment-related safety concerns. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03682809))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Systane Complete (Alcon Inc.).